La maladie de Parkinson au Canada (serveur d'exploration) - Curation (Ncbi)

Index « Keywords » - entrée « Parkinson Disease (economics) »
Attention, ce site est en cours de développement !
Attention, site généré par des moyens informatiques à partir de corpus bruts.
Les informations ne sont donc pas validées.
Parkinson Disease (drug therapy) < Parkinson Disease (economics) < Parkinson Disease (enzymology)  Facettes :

List of bibliographic references

Number of relevant bibliographic references: 13.
Ident.Authors (with country if any)Title
000012 (1998) D. Hailey [Canada] ; C. HarstallPosteroventral pallidotomy for Parkinson's disease: assessment and policy on a technology in transition.
000049 (1999) M. Guttman [Canada] ; O. SuchowerskyParkinson's disease management: towards a new paradigm.
000195 (2001) T. Muir ; M. ZegaracSocietal costs of exposure to toxic substances: economic and health costs of four case studies that are candidates for environmental causation.
000206 (2000) L. McauleyEntacapone: adjunctive use in patients with advanced Parkinson's disease.
000244 (2002) M. Guttman [Canada] ; P M Slaughter ; M E Theriault ; D P Deboer ; C D NaylorParkinsonism in Ontario: physician utilization.
000272 (2003) Michael Iskedjian [Canada] ; Thomas R. EinarsonCost analysis of ropinirole versus levodopa in the treatment of Parkinson's disease.
000285 (2003) Mark Guttman [Canada] ; Pamela M. Slaughter ; Marc-Erick Theriault ; Donald P. Deboer ; C David NaylorBurden of parkinsonism: a population-based study.
000308 (2003) D. Coyle [Canada] ; M. Barbeau ; M. Guttman ; J-F BaladiThe economic evaluation of pharmacotherapies for Parkinson's disease.
000359 (2003) Douglas Coyle [Canada] ; Martin J. Buxton ; Bernie J. O'BrienMeasures of importance for economic analysis based on decision modeling.
000792 (2008) Doug Coyle [Canada] ; Jeremy OakleyEstimating the expected value of partial perfect information: a review of methods.
001674 (2014) Vincent A. Jourdain [Canada] ; Gast N SchechtmannHealth economics and surgical treatment for Parkinson's disease in a world perspective: results from an international survey.
001967 (2014) Suzy L. Wong ; Heather Gilmour ; Pamela L. Ramage-MorinParkinson's disease: Prevalence, diagnosis and impact.
001A47 (2015) Alberto J. Espay ; Matthew M. Norris ; James C. Eliassen ; Alok Dwivedi ; Matthew S. Smith ; Christi Banks ; Jane B. Allendorfer ; Anthony E. Lang ; David E. Fleck ; Michael J. Linke ; Jerzy P. SzaflarskiPlacebo effect of medication cost in Parkinson disease

Pour manipuler ce document sous Unix (Dilib)

EXPLOR_STEP=$WICRI_ROOT/Wicri/Canada/explor/ParkinsonCanadaV1/Data/Ncbi/Curation
HfdIndexSelect -h $EXPLOR_AREA/Data/Ncbi/Curation/KwdEn.i -k "Parkinson Disease (economics)" 
HfdIndexSelect -h $EXPLOR_AREA/Data/Ncbi/Curation/KwdEn.i  \
                -Sk "Parkinson Disease (economics)" \
         | HfdSelect -Kh $EXPLOR_AREA/Data/Ncbi/Curation/biblio.hfd 

Pour mettre un lien sur cette page dans le réseau Wicri

{{Explor lien
   |wiki=    Wicri/Canada
   |area=    ParkinsonCanadaV1
   |flux=    Ncbi
   |étape=   Curation
   |type=    indexItem
   |index=    KwdEn.i
   |clé=    Parkinson Disease (economics)
}}

Wicri

This area was generated with Dilib version V0.6.29.
Data generation: Thu May 4 22:20:19 2017. Site generation: Fri Dec 23 23:17:26 2022